Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Conduction System | 7 | 2012 | 119 | 0.840 |
Why?
|
| Coronary Stenosis | 2 | 2018 | 246 | 0.600 |
Why?
|
| Whales | 1 | 2017 | 6 | 0.590 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 100 | 0.580 |
Why?
|
| Selenium | 1 | 2017 | 36 | 0.570 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 139 | 0.560 |
Why?
|
| Coronary Artery Disease | 3 | 2018 | 696 | 0.550 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 167 | 0.510 |
Why?
|
| Transcription Factors | 6 | 2006 | 753 | 0.480 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 424 | 0.460 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.450 |
Why?
|
| Proteins | 1 | 2017 | 474 | 0.450 |
Why?
|
| Homeodomain Proteins | 6 | 2006 | 157 | 0.440 |
Why?
|
| Iron Metabolism Disorders | 1 | 2011 | 1 | 0.400 |
Why?
|
| Pressure | 1 | 2012 | 252 | 0.380 |
Why?
|
| Exercise Tolerance | 1 | 2011 | 75 | 0.380 |
Why?
|
| Heart Failure | 4 | 2020 | 1180 | 0.370 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2010 | 14 | 0.370 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 36 | 0.370 |
Why?
|
| Anemia | 1 | 2011 | 104 | 0.360 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 116 | 0.340 |
Why?
|
| Iron | 1 | 2011 | 197 | 0.340 |
Why?
|
| Myocytes, Cardiac | 4 | 2012 | 442 | 0.300 |
Why?
|
| Purkinje Fibers | 5 | 2012 | 20 | 0.290 |
Why?
|
| Coronary Angiography | 4 | 2014 | 866 | 0.280 |
Why?
|
| Electrocardiography | 6 | 2015 | 601 | 0.270 |
Why?
|
| Cardiac Tamponade | 1 | 2006 | 11 | 0.270 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2006 | 12 | 0.270 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 33 | 0.260 |
Why?
|
| Arrhythmia, Sinus | 1 | 2005 | 6 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 2324 | 0.250 |
Why?
|
| Atrioventricular Node | 1 | 2005 | 39 | 0.240 |
Why?
|
| Serum Response Factor | 1 | 2002 | 15 | 0.210 |
Why?
|
| Connexins | 5 | 2012 | 35 | 0.210 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 31 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2002 | 69 | 0.200 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 700 | 0.200 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 375 | 0.190 |
Why?
|
| Biphenyl Compounds | 2 | 2020 | 184 | 0.190 |
Why?
|
| Neprilysin | 1 | 2020 | 55 | 0.180 |
Why?
|
| Valsartan | 1 | 2020 | 99 | 0.180 |
Why?
|
| Enalapril | 1 | 2020 | 86 | 0.180 |
Why?
|
| Aminobutyrates | 1 | 2020 | 94 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 155 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 1293 | 0.150 |
Why?
|
| Homeobox Protein Nkx-2.5 | 4 | 2005 | 27 | 0.140 |
Why?
|
| Mutation | 5 | 2005 | 1213 | 0.140 |
Why?
|
| Animals | 12 | 2017 | 20881 | 0.140 |
Why?
|
| Humans | 19 | 2020 | 68618 | 0.140 |
Why?
|
| Myocardium | 3 | 2017 | 1204 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1465 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1083 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2018 | 3705 | 0.120 |
Why?
|
| Mice | 7 | 2012 | 8474 | 0.120 |
Why?
|
| Peptides | 1 | 2017 | 455 | 0.120 |
Why?
|
| Angina, Unstable | 1 | 2014 | 50 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 153 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 147 | 0.110 |
Why?
|
| Middle Aged | 8 | 2018 | 21147 | 0.110 |
Why?
|
| Male | 10 | 2018 | 37321 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 142 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 328 | 0.110 |
Why?
|
| Female | 10 | 2018 | 38074 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 141 | 0.110 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 11 | 0.100 |
Why?
|
| Constriction | 1 | 2012 | 37 | 0.100 |
Why?
|
| Cell Size | 1 | 2012 | 76 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 329 | 0.100 |
Why?
|
| Liver | 1 | 2017 | 1118 | 0.100 |
Why?
|
| Cell Count | 1 | 2012 | 248 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 689 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 209 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2006 | 1034 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.090 |
Why?
|
| Radionuclide Ventriculography | 1 | 2010 | 6 | 0.090 |
Why?
|
| Echocardiography | 2 | 2012 | 515 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 615 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2012 | 213 | 0.090 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 87 | 0.090 |
Why?
|
| Action Potentials | 1 | 2012 | 223 | 0.090 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2010 | 61 | 0.090 |
Why?
|
| Ablation Techniques | 1 | 2010 | 33 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 239 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2550 | 0.090 |
Why?
|
| Calcinosis | 1 | 2011 | 241 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.090 |
Why?
|
| Ventricular Function, Left | 2 | 2010 | 481 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1033 | 0.080 |
Why?
|
| Decision Making | 1 | 2012 | 410 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2012 | 705 | 0.080 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 195 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 318 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 373 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 592 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2005 | 1692 | 0.080 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.070 |
Why?
|
| Aged | 4 | 2018 | 14862 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2009 | 222 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 164 | 0.070 |
Why?
|
| Avian Proteins | 1 | 2006 | 23 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 562 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 95 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2005 | 160 | 0.060 |
Why?
|
| Thiazoles | 1 | 2005 | 95 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2005 | 128 | 0.060 |
Why?
|
| Binding Sites | 2 | 2003 | 631 | 0.060 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 125 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 893 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2010 | 7029 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 1753 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2003 | 62 | 0.050 |
Why?
|
| Bundle of His | 1 | 2003 | 21 | 0.050 |
Why?
|
| Chick Embryo | 4 | 2006 | 379 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2005 | 1451 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2005 | 277 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 81 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2003 | 146 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 272 | 0.050 |
Why?
|
| Cats | 1 | 2002 | 292 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 498 | 0.050 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2002 | 45 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 786 | 0.050 |
Why?
|
| Heart | 2 | 2003 | 850 | 0.050 |
Why?
|
| Angiotensins | 1 | 2020 | 16 | 0.050 |
Why?
|
| Transfection | 1 | 2002 | 782 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.040 |
Why?
|
| DNA | 1 | 2002 | 597 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2002 | 313 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2077 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 2015 | 5 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 33 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 92 | 0.030 |
Why?
|
| Causality | 1 | 2014 | 82 | 0.030 |
Why?
|
| Aorta | 2 | 2005 | 316 | 0.030 |
Why?
|
| Morphogenesis | 2 | 2003 | 159 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2012 | 137 | 0.020 |
Why?
|
| Iohexol | 1 | 2011 | 82 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1140 | 0.020 |
Why?
|
| Artifacts | 1 | 2011 | 125 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 236 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2012 | 275 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 330 | 0.020 |
Why?
|
| Catheterization | 1 | 2011 | 209 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 546 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1603 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1426 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 201 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 2093 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 93 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 595 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2007 | 0.020 |
Why?
|
| South Carolina | 1 | 2014 | 2752 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 233 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2009 | 356 | 0.020 |
Why?
|
| Capillary Resistance | 1 | 2005 | 1 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 49 | 0.020 |
Why?
|
| Compliance | 1 | 2005 | 26 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 20 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2005 | 133 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1196 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2006 | 295 | 0.020 |
Why?
|
| Rats | 2 | 2003 | 5300 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 312 | 0.020 |
Why?
|
| District of Columbia | 1 | 2004 | 23 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2004 | 30 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 172 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2006 | 305 | 0.020 |
Why?
|
| Sp3 Transcription Factor | 1 | 2003 | 4 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 11 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 258 | 0.010 |
Why?
|
| Response Elements | 1 | 2003 | 29 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 21 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 242 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 61 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 490 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 165 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Endothelium | 1 | 2003 | 98 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2005 | 586 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 371 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 396 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 1046 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 97 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2003 | 136 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 447 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 21403 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 1015 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2003 | 122 | 0.010 |
Why?
|
| Gestational Age | 1 | 2003 | 389 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 383 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1447 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2003 | 239 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1027 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 1330 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1664 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2003 | 276 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 1593 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 371 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 1752 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 3259 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 1851 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2673 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 2791 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 2800 | 0.010 |
Why?
|
| Quality of Life | 1 | 2005 | 1515 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 2223 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 2689 | 0.010 |
Why?
|